Elisa G. G.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Trastuzumab Deruxtecan in Unresectable/Metastatic HER2-low or HER2 IHC0 Breast Cancer: A Multicenter, Open-label Study
- Phase 3 Randomized Study of Sacituzumab Govitecan vs. Physician's Choice in PD-L1 Negative or Anti-PD-(L)1 Treated Metastatic Triple-Negative Breast Cancer
- Phase 3 Randomized Study of Sacituzumab Govitecan and Pembrolizumab Versus Physician's Choice and Pembrolizumab in PD-L1 Positive Metastatic Triple-Negative Breast Cancer
Data & Insights
Has run more than one trial at 117 of 355 partner sites.
Specializations
Breast Cancer Therapy
The investigator specializes in treating hormone receptor-positive breast cancer and HER2-negative breast cancer, with particular emphasis on neoadjuvant therapeutic approaches. Their research encompasses both standard chemotherapy protocols and innovative targeted treatments.
- Hormone Receptor-Positive Disease Management
- Neoadjuvant Treatment Strategies
- High-Risk Breast Cancer
Their work focuses on evaluating treatment responses through Residual Cancer Burden assessment.
Long-term Disease Monitoring
The investigator conducts comprehensive research in early-stage breast cancer progression and treatment outcomes. Their expertise extends to monitoring disease evolution and identifying patterns of recurrence in breast cancer patients.
- Disease Progression Analysis
- Relapse Pattern Studies
- Early-Stage Disease Management
Their research includes tracking invasive breast cancer outcomes in both neoadjuvant and adjuvant settings.
Clinical Research Focus
The investigator's expertise encompasses therapeutic innovation in breast oncology, particularly in developing and evaluating treatment strategies for various breast cancer subtypes.
- Treatment Response Evaluation
- Risk Assessment Protocols
- Long-term Survival Analysis
They specialize in analyzing the effectiveness of various therapeutic interventions across different breast cancer stages.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.